optumrx glp 1 coverage Zepbound Coverage: The UnitedHealth Group PBM Reality Home | OptumRx

Cover and refrigerate

A mental health professional should be involved in this decision

Regarding kidney function, the DECREASE trial which enrolled 66 participants with obesity and type 2 diabetes showed a mean percentage change in 24-h urine albumin to creatinine ratio (UACR) of 40% with combination treatment including dapagliflozin and exenatide as opposed to 18% with dapagliflozin, 16% with exenatide and 11% with placebo [8], although between group differences did not reach statistical significance

2014;220(1):R124

Marchetti P, Lupi R, Bugliani M, Kirkpatrick CL, Sebastiani G, Grieco FA, Del Guerra S, D'Aleo V, Piro S, Marselli L, Boggi U, Filipponi F, Tinti L, Salvini L, Wollheim CB, Purrello F, Dotta F

Mounjaro and Ozempic are part of a blockbuster new class of injectable drugs that is significantly changing diabetes treatment